Exosomal Non-Coding RNAs: Novel Regulators of Macrophage-Linked Intercellular Communication in Lung Cancer and

Xingning Lai1,2, Jie Zhong1,2, Boyi Zhang1,2

  • 1Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu 610041, China.

Biomolecules
|March 29, 2023
PubMed

Insights

Exosomes carry non-coding RNAs (ncRNAs) that regulate macrophage communication. These exosomal ncRNAs impact lung cancer progression and inflammatory lung diseases, offering potential therapeutic strategies.

Area of Science:

  • Immunology
  • Molecular Biology
  • Oncology

Background:

  • Macrophages, key innate immune cells, are classified as M1 (pro-inflammatory) and M2 (anti-inflammatory).
  • Exosomes are nanovesicles abundant in non-coding RNAs (ncRNAs), such as microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs).
  • Exosomal ncRNAs play critical roles in intercellular communication and modulating immune responses.

Purpose of the Study:

  • To explore the role of exosomal ncRNAs in macrophage-mediated intercellular communication.
  • To investigate the involvement of exosomal ncRNAs in lung cancer and inflammatory lung disorders.
  • To discuss the therapeutic potential of exosomal ncRNAs for lung diseases.

Main Methods:

  • Literature review and synthesis of existing research on exosomal ncRNAs and macrophages.
  • Analysis of the mechanisms by which exosomal ncRNAs influence macrophage polarization and function.
  • Examination of the impact of exosomal ncRNAs in lung cancer and inflammatory lung conditions.

Main Results:

  • Exosomal ncRNAs mediate communication between lung tumor cells and tumor-associated macrophages (TAMs), influencing cancer hallmarks.
  • In inflammatory lung diseases, exosomal ncRNAs modulate macrophage activation, affecting lung injury, asthma, and fibrosis.
  • Exosomal ncRNAs can either promote or inhibit disease progression depending on the context.

Conclusions:

  • Exosomal ncRNAs are crucial regulators of macrophage behavior in both cancer and inflammatory lung diseases.
  • Targeting exosomal ncRNAs presents a promising avenue for novel therapeutic interventions in lung disorders.
  • Further research into exosomal ncRNA-mediated communication can unlock new treatment strategies.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K